These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12076998)

  • 1. A multigenerational family with multiple sclerosis.
    Dyment DA; Cader MZ; Willer CJ; Risch N; Sadovnick AD; Ebers GC
    Brain; 2002 Jul; 125(Pt 7):1474-82. PubMed ID: 12076998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome scan in a single pedigree with a high prevalence of multiple sclerosis.
    Dyment DA; Cader MZ; Herrera BM; Ramagopalan SV; Orton SM; Chao M; Willer CJ; Sadovnick AD; Risch N; Ebers GC
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):158-62. PubMed ID: 17550985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families.
    Eoli M; Pandolfo M; Amoroso A; Salmaggi A; Zaffaroni M; Gasparini P; DiDonato S; Milanese C; Zeviani M
    Eur J Hum Genet; 1995; 3(5):303-11. PubMed ID: 8556305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
    Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
    Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
    Ligers A; Dyment DA; Willer CJ; Sadovnick AD; Ebers G; Risch N; Hillert J;
    Am J Hum Genet; 2001 Oct; 69(4):900-3. PubMed ID: 11519010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide scan in forty large pedigrees with multiple sclerosis.
    Willer CJ; Dyment DA; Cherny S; Ramagopalan SV; Herrera BM; Morrison KME; Sadovnick AD; Risch NJ; Ebers GC
    J Hum Genet; 2007; 52(12):955-962. PubMed ID: 18000641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
    Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis.
    Chao MJ; Herrera BM; Ramagopalan SV; Deluca G; Handunetthi L; Orton SM; Lincoln MR; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2010 Sep; 19(18):3679-89. PubMed ID: 20634196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.
    DeLuca GC; Ramagopalan SV; Herrera BM; Dyment DA; Lincoln MR; Montpetit A; Pugliatti M; Barnardo MC; Risch NJ; Sadovnick AD; Chao M; Sotgiu S; Hudson TJ; Ebers GC
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20896-901. PubMed ID: 18087043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
    Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
    Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis for clinical expression in multiple sclerosis.
    Barcellos LF; Oksenberg JR; Green AJ; Bucher P; Rimmler JB; Schmidt S; Garcia ME; Lincoln RR; Pericak-Vance MA; Haines JL; Hauser SL;
    Brain; 2002 Jan; 125(Pt 1):150-8. PubMed ID: 11834600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental transmission of HLA-DRB1*15 in multiple sclerosis.
    Ramagopalan SV; Herrera BM; Bell JT; Dyment DA; Deluca GC; Lincoln MR; Orton SM; Chao MJ; Sadovnick AD; Ebers GC
    Hum Genet; 2008 Jan; 122(6):661-3. PubMed ID: 17972102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
    Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Disanto G; Magalhaes S; Handel AE; Morrison KM; Sadovnick AD; Ebers GC; Banwell B; Bar-Or A;
    Neurology; 2011 Mar; 76(9):781-6. PubMed ID: 21288988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12.
    Vitale E; Cook S; Sun R; Specchia C; Subramanian K; Rocchi M; Nathanson D; Schwalb M; Devoto M; Rohowsky-Kochan C
    Hum Mol Genet; 2002 Feb; 11(3):295-300. PubMed ID: 11823448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.